119 related articles for article (PubMed ID: 28246149)
1. Associations between serum levels of calcium, parathyroid hormone and future risk of venous thromboembolism: the Tromsø study.
Lerstad G; Brodin EE; Svartberg J; Jorde R; Brox J; Brækkan SK; Hansen JB
Eur J Endocrinol; 2017 May; 176(5):625-634. PubMed ID: 28246149
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
[TBL] [Abstract][Full Text] [Related]
3. Thyroid function, as assessed by TSH, and future risk of venous thromboembolism: the Tromsø study.
Lerstad G; Enga KF; Jorde R; Brodin EE; Svartberg J; Brækkan SK; Hansen JB
Eur J Endocrinol; 2015 Jul; 173(1):83-90. PubMed ID: 25899580
[TBL] [Abstract][Full Text] [Related]
4. Serum parathyroid hormone levels predict coronary heart disease: the Tromsø Study.
Kamycheva E; Sundsfjord J; Jorde R
Eur J Cardiovasc Prev Rehabil; 2004 Feb; 11(1):69-74. PubMed ID: 15167209
[TBL] [Abstract][Full Text] [Related]
5. Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study.
Rinde LB; Småbrekke B; Mathiesen EB; Løchen ML; Njølstad I; Hald EM; Wilsgaard T; Brækkan SK; Hansen JB
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27821402
[TBL] [Abstract][Full Text] [Related]
6. Carotid atherosclerosis predicts future myocardial infarction but not venous thromboembolism: the Tromso study.
Hald EM; Lijfering WM; Mathiesen EB; Johnsen SH; Løchen ML; Njølstad I; Wilsgaard T; Rosendaal FR; Brækkan SK; Hansen JB
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):226-30. PubMed ID: 24177328
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia, assessed according to HbA1c , and future risk of venous thromboembolism: the Tromsø study.
Lerstad G; Brodin EE; Enga KF; Jorde R; Schirmer H; Njølstad I; Svartberg J; Braekkan SK; Hansen JB
J Thromb Haemost; 2014; 12(3):313-9. PubMed ID: 24382156
[TBL] [Abstract][Full Text] [Related]
8. Body height and risk of venous thromboembolism: The Tromsø Study.
Braekkan SK; Borch KH; Mathiesen EB; Njølstad I; Wilsgaard T; Hansen JB
Am J Epidemiol; 2010 May; 171(10):1109-15. PubMed ID: 20418276
[TBL] [Abstract][Full Text] [Related]
9. Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study.
Svartberg J; Braekkan SK; Laughlin GA; Hansen JB
Eur J Endocrinol; 2009 May; 160(5):833-8. PubMed ID: 19208774
[TBL] [Abstract][Full Text] [Related]
10. Heart healthy diet and risk of myocardial infarction and venous thromboembolism. The Tromsø Study.
Hansen-Krone IJ; Enga KF; Njølstad I; Hansen JB; Braekkan SK
Thromb Haemost; 2012 Sep; 108(3):554-60. PubMed ID: 22739999
[TBL] [Abstract][Full Text] [Related]
11. COPD and risk of venous thromboembolism and mortality in a general population.
Børvik T; Brækkan SK; Enga K; Schirmer H; Brodin EE; Melbye H; Hansen JB
Eur Respir J; 2016 Feb; 47(2):473-81. PubMed ID: 26585434
[TBL] [Abstract][Full Text] [Related]
12. Serum parathyroid hormone level is associated with body mass index. The 5th Tromsø study.
Kamycheva E; Sundsfjord J; Jorde R
Eur J Endocrinol; 2004 Aug; 151(2):167-72. PubMed ID: 15296470
[TBL] [Abstract][Full Text] [Related]
13. Red cell distribution width is associated with incident venous thromboembolism (VTE) and case-fatality after VTE in a general population.
Ellingsen TS; Lappegård J; Skjelbakken T; Brækkan SK; Hansen JB
Thromb Haemost; 2015 Jan; 113(1):193-200. PubMed ID: 25274492
[TBL] [Abstract][Full Text] [Related]
14. Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the Tromsø Study.
Småbrekke B; Rinde LB; Hald EM; Njølstad I; Mathiesen EB; Johnsen SH; Hansen JB; Braekkan SK; Lijfering WM
J Thromb Haemost; 2017 Dec; 15(12):2344-2351. PubMed ID: 28981216
[TBL] [Abstract][Full Text] [Related]
15. Weight Change and Risk of Venous Thromboembolism: The Tromsø Study.
Horvei LD; Brækkan SK; Hansen JB
PLoS One; 2016; 11(12):e0168878. PubMed ID: 27997594
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein, obesity, and the risk of arterial and venous thrombosis.
Horvei LD; Grimnes G; Hindberg K; Mathiesen EB; Njølstad I; Wilsgaard T; Brox J; Braekkan SK; Hansen JB
J Thromb Haemost; 2016 Aug; 14(8):1561-71. PubMed ID: 27208592
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism increases the risk of atrial fibrillation: the Tromso study.
Hald EM; Enga KF; Løchen ML; Mathiesen EB; Njølstad I; Wilsgaard T; Braekkan SK; Hansen JB
J Am Heart Assoc; 2014 Jan; 3(1):e000483. PubMed ID: 24385452
[TBL] [Abstract][Full Text] [Related]
18. Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø Study, Tromsø, Norway.
Braekkan SK; Mathiesen EB; Njølstad I; Wilsgaard T; Størmer J; Hansen JB
J Thromb Haemost; 2010 Jan; 8(1):157-62. PubMed ID: 19496920
[TBL] [Abstract][Full Text] [Related]
19. Complement activation assessed by the plasma terminal complement complex and future risk of venous thromboembolism.
Høiland II; Liang RA; Braekkan SK; Pettersen K; Ludviksen JK; Latysheva N; Snir O; Ueland T; Hindberg K; Mollnes TE; Hansen JB
J Thromb Haemost; 2019 Jun; 17(6):934-943. PubMed ID: 30920726
[TBL] [Abstract][Full Text] [Related]
20. Family history of myocardial infarction and cause-specific risk of myocardial infarction and venous thromboembolism: the Tromsø Study.
Lind C; Enga KF; Mathiesen EB; Njølstad I; Brækkan SK; Hansen JB
Circ Cardiovasc Genet; 2014 Oct; 7(5):684-91. PubMed ID: 25087051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
